MN
Mukta Narsingrao Pawar
About Mukta Narsingrao Pawar
Mukta Narsingrao Pawar has 6 years in corporate governance. Holds Additional Director and Director roles. Currently with 2 companies, including Govind Hospital And Other Speciality Services Private Limited and Mm Solutions Private Limited. Formerly with 1 company, such as Arc Test House & Consultants Llp. Engaged in General Business. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Govind Hospital And Other Speciality Services Private Limited
U74999MH2016PTC287560
|
Additional Director | 27 Nov 2019 | 2016 | Active |
Mm Solutions Private Limited
U46630AS2025PTC029354
|
Director | 08 Dec 2025 | 2025 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Arc Test House & Consultants Llp
AAI-6774
|
Designated Partner | 06 Jan 2022 | 2017 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mukta Narsingrao Pawar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mukta Narsingrao Pawar
Mukta Narsingrao Pawar has 6 years in corporate governance. Holds Additional Director and Director roles. Currently with 2 companies, including Govind Hospital And Other Speciality Services Private Limited and Mm Solutions Private Limited. Formerly with 1 company, such as Arc Test House & Consultants Llp. Engaged in General Business. Contributes to corporate operations.
Mukta Narsingrao Pawar is associated with 2 companies as Additional Director and Director.
Mukta Narsingrao Pawar has expertise in General Business.
Mukta Narsingrao Pawar has 6 years in corporate governance.